Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
Clinical Pharmacology and Therapeutics|April 16, 2016
Pregnancy-related pharmacokinetic changesY Tasnif, J Morado, M F HebertClinical Pharmacology and Therapeutics|October 18, 2012
Measurement and compartmental modeling of the effect of CYP3A5 gene variation on systemic and intrarenal tacrolimus dispositionS Zheng, Y Tasnif, M F Hebert, et al.The Annals of Pharmacotherapy|July 20, 1999
Diltiazem increases tacrolimus concentrationsM F Hebert, A Y LamThe Annals of Pharmacotherapy|October 1, 1993
Endstage liver disease associated with nitrofurantoin requiring liver transplantationM F Hebert, J P RobertsDICP : the Annals of Pharmacotherapy|July 1, 1990
What is the clinical role of aerosolized ribavirin?M F Hebert, B J GuglielmoClinical Pharmacology and Therapeutics|March 1, 1996
The effect of water-soluble vitamin E on cyclosporine pharmacokinetics in healthy volunteersT Chang, L Z Benet, M F HebertClinical Pharmacology and Therapeutics|November 1, 1992
Bioavailability of cyclosporine with concomitant rifampin administration is markedly less than predicted by hepatic enzyme inductionM F Hebert, J P Roberts, T Prueksaritanont, et al.Journal of Clinical Pharmacology|February 13, 1999
Effects of rifampin on tacrolimus pharmacokinetics in healthy volunteersM F Hebert, R M Fisher, C L Marsh, et al.The Pharmacogenomics Journal|May 12, 2016
Prenatal pharmacogenomics: a promising area for researchE H Dorfman, E Y Cheng, M F Hebert, et al.International Journal of Molecular Sciences|June 27, 2024
The Gap Junction Inhibitor Octanol Decreases Proliferation and Increases Glial Differentiation of Postnatal Neural Progenitor CellsRocío Talaverón, Camilo J Morado-Díaz, Alejandro Herrera, et al.Pageof 4